Psittimune® APV successfully prevents infection and death from avian polyomavirus in parrots. This vaccine for birds is a killed vaccine and a patented avian polyomavirus containing an antigenic isolate of avian polyomavirus. Psittimune® APV vaccine aids in the prevention of avian polyomavirus infection prior to virus exposure and is the only federally licensed product of its kind.
The polyomavirus vaccine for birds is recommended for young, healthy psittacine birds. Young birds should initially be vaccinated at 5 weeks (35 days) of age. To complete primary immunization, a second dose of this APV vaccine must be given two to three weeks following initial vaccination. Annual revaccination is recommended and susceptible breeders should be vaccinated prior to laying season.
For parrots 35 days of age or older.